Doença renal crônica (DRC) is a progressive condition that affects millions of people worldwide. In its late stages, CKD can lead to kidney failure, requiring dialysis or a kidney transplant. Terapia com células-tronco has emerged as a potential treatment option for late-stage CKD, oferecendo esperança para pacientes com esta condição debilitante.
Late-Stage Chronic Kidney Disease: Uma visão geral
Late-stage CKD is characterized by a significant decline in kidney function, often leading to a buildup of toxins and fluid in the body. This can cause a range of symptoms, including fatigue, náusea, inchaço, and difficulty concentrating. As the disease progresses, patients may experience kidney failure, requiring dialysis or a kidney transplant to survive.
Terapia com células-tronco: A Potential Treatment Option
As células-tronco são células não especializadas que têm a capacidade de se diferenciar em vários tipos de células., including kidney cells. Researchers believe that terapia com células-tronco could potentially regenerate damaged kidney tissue and restore kidney function in patients with late-stage CKD.
